Spearhead Capital Advisors’s NEVRO CORP. NVRO Stock Holding History

Spearhead Capital Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,110	Closed	-$248K	–	136
2019 Q4	$248K	Buy	+2,110	New	+$209K	0.06%	88

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Spearhead Capital Advisors's NVRO Position: Q1 2020 in Review

Spearhead Capital Advisors sold out of NEVRO CORP. (NVRO) in Q1 2020, closing a stake of 2,110 shares — an estimated $248K sold.

Spearhead Capital Advisors first reported a position in NVRO in Q4 2019 and held it in 1 quarter. The position peaked at $248K in Q4 2019. 182 funds tracked by Wall St. Rank hold NVRO as of Q1 2020.

Spearhead Capital Advisors reported no remaining NEVRO CORP. position as of Q1 2020 after selling out during the quarter.
Spearhead Capital Advisors sold 2,110 NEVRO CORP. shares in Q1 2020, an estimated $248K.
Spearhead Capital Advisors first reported a position in NEVRO CORP. in Q4 2019 and held it in 1 quarter.
Spearhead Capital Advisors's NEVRO CORP. position peaked at $248K in Q4 2019.
182 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2020.

Based on Spearhead Capital Advisors's 13F filing for Q1 2020, filed 17 Apr 2020.